Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Made In Korea: Local Device Companies Overtake Multinationals In Product Approvals

This article was originally published in PharmAsia News

Executive Summary

Korea approved 3,100 new medical devices in 2012, with domestic products overtaking imported products for the first time.

You may also be interested in...



Samsung Electronics Takes Over Leading Medical Device Maker Medison

SEOUL - South Korea's Samsung Electronics is further building its burgeoning presence in the healthcare sector through the takeover of the country's leading medical equipment maker Medison Co. from a private equity fund

South Korea To Strengthen Medical Equipment Sector

SEOUL - Ahead of the July 2011 launch of Korea-EU free trade agreement, which local observers fear could damage the local healthcare sector, the Korean government is hammering out a set of measures to help the country's medical equipment industry

Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III

Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC084531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel